SecBot SecBot
6-K ·Filed Apr 7, 2026

NONOF

NOVO NORDISK A S
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001171843-26-002279
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine capital return program. Traders should monitor the pace of repurchases and any changes in the company's financial guidance, but no immediate stock price impact is expected from this announcement alone.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
NONOF ▲ +39.20% at T+60d
NEUTRAL call +39.20% · α vs SPY +25.93% · entry $35.92 → $50.00
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
-2.48%
call -2.48% · α -5.02%
$35.03
settled 7mo ago
T+5d
+8.07%
call +8.07% · α +2.74%
$38.82
settled 7mo ago
T+20d
+23.47%
call +23.47% · α +13.69%
$44.35
settled 6mo ago
T+60d
+39.20%
call +39.20% · α +25.93%
$50.00
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Novo Nordisk announced a share repurchase program of up to DKK 15 billion over 12 months, with DKK 2.59 billion already executed by April 1, 2026. This is a routine capital allocation action.

Key Facts

  • Novo Nordisk initiated a share repurchase program of up to DKK 15 billion starting February 4, 2026
  • As of April 1, 2026, the company has repurchased 9,967,992 B shares for DKK 2.59 billion at an average price of DKK 259.47 per share
  • The repurchased shares represent 0.6% of the company's share capital

Financial Impact

DKK 15 billion ($2.03 billion) total program, with DKK 2.59 billion ($352 million) already executed

cashshares outstandingdilution

Risk Factors

  • The repurchase program could be scaled back if market conditions change or financial performance deteriorates
  • The program represents a use of capital that could otherwise be invested in R&D or acquisitions

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-002279
Document: 0001171843-26-002279-index-headers.html0001171843-26-002279
Document: 0001171843-26-002279-index.html0001171843-26-002279
Document: 0001171843-26-002279.txt0001171843-26-002279
6 reports for NONOF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NONOF — sortable, filterable
TypeNow
Jun 8, 2026
20w ago
6-K
NEUTRAL ★ 3/10
$41.25 $46.09▲ +11.73%▲ +8.42%$38.98 (−5.50%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 3/10
$44.80 $46.30▲ +3.35%▲ +1.47%$38.98 (−12.99%)
May 22, 2026
22w ago
6-K
BULLISH ★ 7/10
$43.80 $44.78▲ +2.24%▼ −0.95%$38.98 (−11.00%)
Apr 13, 2026
28w ago
6-K
NEUTRAL ★ 4/10
$38.08 $49.85▲ +30.91%▲ +21.99%$38.98 (+2.36%)
Apr 7, 2026
29w ago
6-K
NEUTRAL ★ 3/10
$35.92 $50.00▲ +39.20%▲ +25.93%$38.98 (+8.52%)
Mar 27, 2026
30w ago
6-K
NEUTRAL ★ 2/10
$35.29 $46.84▲ +32.73%▲ +16.66%$38.98 (+10.46%)
Showing 6 of 6

US Market Status

Market Closed — Opens Thu (9h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026